DAVIS RICHARD E 4
4 · Arch Therapeutics, Inc. · Filed Jul 20, 2018
Insider Transaction Report
Form 4
DAVIS RICHARD E
CFO & TREASURER
Transactions
- Award
Common Stock
2018-07-19+275,000→ 878,000 total - Award
Stock Option (right to buy)
2018-07-19+275,000→ 275,000 totalExercise: $0.42Exp: 2028-07-18→ Common Stock (275,000 underlying)
Footnotes (2)
- [F1]Of the Shares subject to this grant, all are issued pursuant to the 2013 Stock Incentive Plan (the "Plan") and 100% shall fully vest on the second anniversary of the date of grant. In addition, in the event of a Change of Control (as such term is defined in the Plan) 100% of grant will immediately vest.
- [F2]Of the Shares subject to this Grant, 25% shall vest immediately and 1/36 of the remaining shares shall vest on each of the next thirty-six (36) monthly anniversaries of the vesting commencement date.